Particle radiotherapy for prostate cancer

Area of Science:

• Oncology
• Radiation Oncology
• Medical Physics

Background:

• External beam radiotherapy advances enable higher tumor doses with reduced normal tissue exposure.
• High-precision radiotherapy, including intensity-modulated radiation therapy (IMRT), has improved prostate cancer treatment outcomes.
• Particle radiotherapy, utilizing protons and carbon ions, is an emerging non-invasive modality for cancer treatment.

Purpose of the Study:

• To review the literature on particle radiotherapy for prostate cancer.
• To discuss the physical and radiobiological properties of particle radiotherapy.
• To compare the merits of particle radiotherapy (proton and carbon ion) with photon-based radiotherapy for prostate cancer.

Main Methods:

• Literature review of particle radiotherapy for prostate cancer.
• Analysis of physical advantages of proton and carbon ion beams (focused dose deposition).
• Evaluation of radiobiological advantages of carbon ions (enhanced efficacy against resistant, hypoxic, and specific cell cycle phase tumors).

Main Results:

• Protons and carbon ions offer superior dose conformity to tumors, minimizing exposure to surrounding tissues.
• Carbon ions possess radiobiological advantages, potentially increasing efficacy against radioresistant and hypoxic prostate cancer cells.
• The clinical benefit of particle radiotherapy for prostate cancer requires further determination.

Conclusions:

• Particle radiotherapy, particularly proton and carbon ion therapy, presents significant physical and radiobiological advantages for prostate cancer treatment.
• While theoretical benefits are substantial, further clinical studies are essential to establish the definitive role and comparative efficacy of particle radiotherapy against established photon-based techniques.